https://orcid.org/0000-0002-2801-5330
Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (33)
Dongdong Liu, Xingliang Dai, Zhenchao Tao, Hu Zhou, Wenqing Hong, Haisheng Qian, Hongwei Cheng & Xianwen Wang. (2023) Advances in blood–brain barrier-crossing nanomedicine for anti-glioma. Cancer Nanotechnology 14:1.
Crossref
Crossref
Nadia Allahyarzadeh Khiabani, Mohammad Amin Doustvandi, Fateme Mohammadnejad, Elnaz Salmani Hassan Kohal, Neda Boushehri, Mahdi Jafarlou & Behzad Baradaran. (2023) Combination of B7H6-siRNA and temozolomide synergistically reduces stemness and migration properties of glioblastoma cancer cells. Experimental Cell Research 429:1, pages 113667.
Crossref
Crossref
Mehrab Pourmadadi, Amin Shamsabadipour, Atiya Bhatti, Mahboobeh Forouzanfar, Mohaddeseh Rajabnejad, Razieh Behzadmehr, Abbas Rahdar, Dora Iliana Medina & Ana M. Díez-Pascual. (2023) Therapeutic performance of temozolomide-loaded nanomaterials: A state-of-the-art. Journal of Drug Delivery Science and Technology 85, pages 104568.
Crossref
Crossref
Rakesh Kumar Sahoo, Hitesh Kumar, Vikas Jain, Sonal Sinha, Ajazuddin & Umesh Gupta. (2023)
Angiopep-2 Grafted PAMAM Dendrimers for the Targeted Delivery of Temozolomide:
In Vitro
and
In Vivo
Effects of PEGylation in the Management of Glioblastoma Multiforme
. ACS Biomaterials Science & Engineering 9:7, pages 4288-4301.
Crossref
Crossref
Zahra Nozhat, Shabnam Heydarzadeh, Mina Shahriari-Khalaji, Shibo Wang, M. Zubair Iqbal & Xiangdong Kong. (2023) Advanced biomaterials for human glioblastoma multiforme (GBM) drug delivery. Biomaterials Science 11:12, pages 4094-4131.
Crossref
Crossref
Timofey Lebedev, Rubina Kousar, Bbumba Patrick, Muhammad Usama, Meng-Kuei Lee, Ming Tan & Xing-Guo Li. (2023) Targeting ARID1A-Deficient Cancers: An Immune-Metabolic Perspective. Cells 12:6, pages 952.
Crossref
Crossref
Vishwanath Kurawattimath, Barnabas Wilson & Kannoth Mukundan Geetha. (2023) Nanoparticle-based drug delivery across the blood-brain barrier for treating malignant brain glioma. OpenNano 10, pages 100128.
Crossref
Crossref
Hongyan Liu, Xialin Zhu, Yuyan Wei, Chunhong Song & Yunshan Wang. (2023) Recent advances in targeted gene silencing and cancer therapy by nanoparticle-based delivery systems. Biomedicine & Pharmacotherapy 157, pages 114065.
Crossref
Crossref
Meirong Li, Zheng‐Ian Lin, Jingyu Yang, Haoqiang Huang, Guan‐Lin Liu, Qiqi Liu, Xinmeng Zhang, Ying Zhang, Zhourui Xu, Haoming Lin, Yujuan Chai, Xin Chen, Bao‐Tsan Ko, Jia Liu, Chih‐Kuang Chen & Chengbin Yang. (2022) Biodegradable Carbon Dioxide‐Derived Non‐Viral Gene Vectors for Osteosarcoma Gene Therapy. Advanced Healthcare Materials 12:3, pages 2201306.
Crossref
Crossref
Sofia Parrasia, Ildikò Szabò, Mario Zoratti & Lucia Biasutto. (2022) Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges. Molecular Pharmaceutics 19:11, pages 3700-3729.
Crossref
Crossref
Karishma Shetty, Soma Yasaswi, Shilpee Dutt & Khushwant S. Yadav. (2022) Multifunctional nanocarriers for delivering siRNA and miRNA in glioblastoma therapy: advances in nanobiotechnology-based cancer therapy. 3 Biotech 12:11.
Crossref
Crossref
Ying-Shi Yuan, Xin Jin, Lu Chen, Jia-Min Liao, Yang Zhang, Ke-Wei Yu, Wei-Kang Li, Shun-Wang Cao, Xian-Zhang Huang & Chun-Min Kang. (2022) A novel model based on necroptosis-related genes for predicting immune status and prognosis in glioma. Frontiers in Immunology 13.
Crossref
Crossref
Ana Raquel Neves, Tânia Albuquerque, Rúben Faria, Ana M. Gonçalves, Cecília Santos, Eric Vivès, Prisca Boisguérin, Luís A. Passarinha, Ângela Sousa & Diana Costa. (2022) Development of WRAP5 Peptide Complexes for Targeted Drug/Gene Co-Delivery toward Glioblastoma Therapy. Pharmaceutics 14:10, pages 2213.
Crossref
Crossref
Muhammad Ismail, Wen Yang, Yanfei Li, Yibin Wang, Wenya He, Jiefei Wang, Pir Muhammad, Timothy B. Chaston, Fawad Ur Rehman, Meng Zheng, David B. Lovejoy & Bingyang Shi. (2022) Biomimetic Dp44mT-nanoparticles selectively induce apoptosis in Cu-loaded glioblastoma resulting in potent growth inhibition. Biomaterials 289, pages 121760.
Crossref
Crossref
Jayaprakash Mandal, Prativa Mandal, Tian-Li Wang & Ie-Ming Shih. (2022) Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response. Journal of Biomedical Science 29:1.
Crossref
Crossref
Fatemeh Madani, Seyedeh Sara Esnaashari, Thomas J. Webster, Masood Khosravani & Mahdi Adabi. (2022) Polymeric nanoparticles for drug delivery in glioblastoma: State of the art and future perspectives. Journal of Controlled Release 349, pages 649-661.
Crossref
Crossref
Meihua Luo, Leo Kit Cheung Lee, Bo Peng, Chung Hang Jonathan Choi, Wing Yin Tong & Nicolas H. Voelcker. (2022) Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases. Advanced Science 9:26.
Crossref
Crossref
Zhen Wang, Yuyang Liu, Yong Xiao, Yandong Xie, Ran Wang, Yiding Zhang, Qi Zhou, Liang Liu, Shuo Sun, Hong Xiao, Yuanjie Zou, Kun Yang, Xiang Li, Mengjie Zhao, Yifang Hu & Hongyi Liu. (2022) Intelligent Nanoparticles With pH-Sensitive Co-Delivery of Temozolomide and siEGFR to Ameliorate Glioma Therapy. Frontiers in Genetics 13.
Crossref
Crossref
Xin-Qi Teng, Jian Qu, Guo-Hua Li, Hai-Hui Zhuang & Qiang Qu. (2022) Small Interfering RNA for Gliomas Treatment: Overcoming Hurdles in Delivery. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Yan-Qing Fei, Ru-Ting Shi, Yang-Fan Zhou, Jin-Ze Wu & Zhi Song. (2022) Mannose inhibits proliferation and promotes apoptosis to enhance sensitivity of glioma cells to temozolomide through Wnt/β-catenin signaling pathway. Neurochemistry International 157, pages 105348.
Crossref
Crossref
Yi-Shu Zhou, Wei Wang, Na Chen, Li-Cui Wang & Jin-Bai Huang. (2022) Research progress of anti-glioma chemotherapeutic drugs (Review). Oncology Reports 47:5.
Crossref
Crossref
Zihao Liu, Xiaoshuai Ji, Dong He, Rui Zhang, Qian Liu & Tao Xin. (2022) Nanoscale Drug Delivery Systems in Glioblastoma. Nanoscale Research Letters 17:1.
Crossref
Crossref
Jessica Gasparello, Chiara Papi, Matteo Zurlo, Laura Gambari, Andrea Rozzi, Alex Manicardi, Roberto Corradini, Roberto Gambari & Alessia Finotti. (2022) Treatment of Human Glioblastoma U251 Cells with Sulforaphane and a Peptide Nucleic Acid (PNA) Targeting miR-15b-5p: Synergistic Effects on Induction of Apoptosis. Molecules 27:4, pages 1299.
Crossref
Crossref
Saffiya Habib & Moganavelli Singh. (2022) Angiopep-2-Modified Nanoparticles for Brain-Directed Delivery of Therapeutics: A Review. Polymers 14:4, pages 712.
Crossref
Crossref
Junjie Zhao, Lixia Xu, Zihui Dong, Yize Zhang, Junhua Cao, Jie Yao & Jiyuan Xing. (2022) The LncRNA DUXAP10 Could Function as a Promising Oncogene in Human Cancer. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Ivana Jarak, Miguel Pereira-Silva, Ana Cláudia Santos, Francisco Veiga, Horacio Cabral & Ana Figueiras. (2021) Multifunctional polymeric micelle-based nucleic acid delivery: Current advances and future perspectives. Applied Materials Today 25, pages 101217.
Crossref
Crossref
Dejun Wu, Jinzhang Sun, Hongliang Wang & Chunchun Ma. (2021) LncRNA SOCS2-AS1 promotes the progression of glioma via regulating ITGB1 expression. Neuroscience Letters 765, pages 136248.
Crossref
Crossref
Leonardo Delello Di Filippo, Juliana Hofstätter Azambuja, Jessyca Aparecida Paes Dutra, Marcela Tavares Luiz, Jonatas Lobato Duarte, Luiza Ribeiro Nicoleti, Sara Teresinha Olalla Saad & Marlus Chorilli. (2021) Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers. European Journal of Pharmaceutics and Biopharmaceutics 168, pages 76-89.
Crossref
Crossref
P. Soma Yasaswi, Karishma Shetty & Khushwant S. Yadav. (2021) Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy. Journal of Controlled Release 336, pages 549-571.
Crossref
Crossref
Sepideh Mirzaei, Mohammad Hossein Gholami, Farid Hashemi, Amirhossein Zabolian, Kiavash Hushmandi, Vahid Rahmanian, Maliheh Entezari, Yarabahally R. Girish, Kothanahally S. Sharath Kumar, Amir Reza Aref, Pooyan Makvandi, Milad Ashrafizadeh, Ali Zarrabi & Haroon Khan. (2021) Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: Approaching to a new era of cancer chemotherapy. Life Sciences 277, pages 119430.
Crossref
Crossref
Rossella Basilotta, Deborah Mannino, Alessia Filippone, Giovanna Casili, Angela Prestifilippo, Lorenzo Colarossi, Gabriele Raciti, Emanuela Esposito & Michela Campolo. (2021) Role of Calixarene in Chemotherapy Delivery Strategies. Molecules 26:13, pages 3963.
Crossref
Crossref
Xueyuan Sun & Sevin Turcan. (2021) From Laboratory Studies to Clinical Trials: Temozolomide Use in IDH-Mutant Gliomas. Cells 10:5, pages 1225.
Crossref
Crossref
Miguel Pereira-Silva, Ivana Jarak, Ana Cláudia Santos, Francisco Veiga & Ana Figueiras. (2020) Micelleplex-based nucleic acid therapeutics: From targeted stimuli-responsiveness to nanotoxicity and regulation. European Journal of Pharmaceutical Sciences 153, pages 105461.
Crossref
Crossref